Frontiers in Nutrition · 2022 · 30 citations · 28 references
PharmacyPharmacologyPharmacotherapyAntimicrobial PharmacologyBioavailabilityGastrointestinal PharmacotherapyConstipation ManagementGastrointestinal PharmacologyLaxative TherapyConstipation PathophysiologyDrug-induced Constipation ManagementFunctional Constipation TherapyLaxative PharmacologyLoperamide Therapy
In this study, the laxative effect of Bacillus coagulans BC01 (BC01) in mice was investigated using a functional constipation mouse model. Six-week-old male specific pathogen-free (SPF) Kunming mice were randomly divided into five groups: normal control group (saline), model group (loperamide hydrochloride), drug control group (bisacodyl), BC01 low-dose group (4.0 × 10 8 CFU/mL) and BC01 high-dose group (4.0 × 10 9 CFU/mL). Except for the normal group, the functional constipation model was established by administering 0.25 mL of a loperamide hydrochloride suspension (1 mg/mL) twice daily for four consecutive days by oral gavage. After modeling, the BC01 groups were administered 0.25 mL of BC01. The bisacodyl served as a control and was administered orally at a dose of 100 mg/kg, while the other groups were administered 0.25 mL of sterile saline. After 7 days of continuous administration, the experimental mice were again induced by loperamide hydrochloride. During this period, the mechanism of BC01 to improve constipation symptoms in mice was analyzed by measuring the changes in body weight, fecal water content, small intestine propulsion rate, histology of small intestinal tissue sections, fecal microbial diversity, serum indices, as well as mRNA and protein expression levels in the small intestinal tissue. BC01 was found to significantly promote the intestinal propulsion rate and increase the fecal water content in the mice. BC01 could also alleviates constipation by regulating gastrointestinal motility (substance P, motilin, endothelin-1, somatostatin, and vasoactive intestinal peptide), gene expression ( c-Kit, SCF, COX-2, NF- κ B, iNOS , and eNOS ), intestinal inflammation (eNOS, iNOS, NF-κB), and the intestinal microbiota composition in the constipated mice. In addition, the high-dose BC01 treatment had the best preventive effect on constipation. BC01 is a probiotic strain to effectively relieve the adverse effects of constipation.
28
Gopanandan Parthasarathy, Jun Chen, Xianfeng Chen et al. · Gastroenterology · 2015 · 396 citations · Full text
Azliza Ibrahim, Raja Affendi Raja Ali, Mohd Rizal Abdul Manaf et al. · PLoS ONE · 2020 · 175 citations · Full text
Veronica Ojetti, Gianluca Ianiro, Annalisa Tortora et al. · Journal of Gastrointestinal and Liver Diseases · 2014 · 122 citations · Full text